India markets open in 38 minutes

Arcutis Biotherapeutics, Inc. (ARQT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
23.33-0.32 (-1.35%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
0
0
0
0
0
Operating expenses
Research development
1,11,757
1,15,308
36,522
17,940
3,411
Selling general and administrative
32,322
21,337
6,610
1,795
695
Total operating expenses
1,44,079
1,36,645
43,132
19,735
4,106
Operating income or loss
-1,44,079
-1,36,645
-43,132
-19,735
-4,106
Total other income/expenses net
372
967
1,136
480
-872
Income before tax
-1,43,707
-1,35,678
-41,996
-19,255
-4,978
Income from continuing operations
-1,43,707
-1,35,678
-41,996
-19,255
-4,978
Net income
-1,43,707
-1,35,678
-41,996
-19,255
-4,978
Net income available to common shareholders
-1,43,707
-1,35,678
-41,996
-19,330
-4,978
Basic EPS
-
-3.80
-1.20
-1.10
-0.28
Diluted EPS
-
-3.80
-1.20
-1.10
-0.28
Basic average shares
-
35,668
35,064
17,502
18,035
Diluted average shares
-
35,668
35,064
17,502
18,035
EBITDA
-
-1,36,523
-42,937
-19,735
-4,106